The battle against cervical cancer has long plagued Malian women, with many facing delayed diagnoses and exorbitant treatment costs. Take the case of Fatoumata, a 38-year-old woman who endured years of suffering before discovering she had the disease.

With this initiative, Mali aims to shield over 320,000 girls annually, potentially reducing cervical cancer cases by nearly 90% and preventing more than 3,600 deaths each year among Malian women.

Her story highlights the harsh realities faced by countless women who endure late-stage diagnoses and the financial burden of treatments that are often out of reach in Mali, where access to quality healthcare remains a challenge.

Cervical cancer: a silent epidemic in Mali

Cervical cancer, caused by persistent infection with certain strains of HPV, is a pressing public health crisis in Mali. It ranks as the second most common cancer among women aged 15 to 44 in the country. Tragically, this disease is frequently detected too late, resulting in thousands of preventable deaths annually.

Cultural taboos further exacerbate the problem, as many women hesitate to openly discuss their symptoms. Superstitions often link the disease to curses or spells, delaying diagnosis and worsening outcomes. “Cervical cancer is sometimes perceived as a curse cast by a co-wife, sister-in-law, or former partner,” explains a reproductive health advocate.

Revolutionary step: introducing the HPV vaccine

A historic milestone has been achieved with Mali’s recent integration of the HPV vaccine into its routine immunization schedule. At the launch event in Bamako, Dr. Ibrahima Diarra, Director of the National Immunization Center, emphasized the breakthrough: “A single dose can protect a 10-year-old girl for over a decade against the viruses responsible for 70% of cervical cancers.” Thanks to support from Gavi and co-financing from the Malian government, the vaccine is now provided free of charge to young girls.

Mali’s initiative aims to protect over 320,000 girls every year, with the potential to slash cervical cancer cases by nearly 90% and prevent more than 3,600 deaths annually among Malian women.

Advancing health equity through vaccination

This vaccination program marks a significant stride toward health equity in public health. Cervical cancer claims thousands of lives daily, disproportionately affecting women in low-income countries. In 2022 alone, 348,000 deaths were recorded globally, with 90% occurring in these nations. By introducing the HPV vaccine, Mali is taking a bold step to ensure prevention is accessible to all girls, regardless of whether they live in urban or rural areas.

Dr. Diarra explains the rationale behind targeting 10-year-old girls: “We chose this age group because their cervix is still healthy, long before sexual activity begins, ensuring maximum vaccine efficacy.” This approach aligns with the World Health Organization’s (WHO) recommendation to prioritize vaccination for girls aged 9 to 14.

Mali stands as one of the first Sahelian nations—and the first conflict-affected, fragile country supported by Gavi—to introduce the HPV vaccine.

By preventing cervical cancer, the introduction of the HPV vaccine also reduces the financial burden of treating the disease. “A single dose costs around 150,000 FCFA in private pharmacies, but thanks to Gavi’s support and Malian government co-financing, the vaccine is now free through the routine immunization program,” Dr. Diarra notes.

Mali’s pioneering initiative not only safeguards generations of Malian women but also sets an inspiring example for other countries in the region. This landmark achievement aligns with Gavi’s global goals to vaccinate 86 million girls in low- and middle-income countries by 2025.

Combating misinformation and myths

Malian health authorities face another critical challenge: misinformation. Rumors and fake news sometimes circulate about vaccines, fueled by opponents. “It is crucial to counter this misinformation. This vaccine is safe, effective, and does not compromise fertility or reproductive health in young girls,” insists Dr. Diarra.

Health Minister Colonel Assa Badiallo Touré also reaffirmed the vaccine’s safety and importance during the launch.

The introduction of the HPV vaccine represents a monumental victory for women’s health and a step toward a more equitable future in Mali. By breaking the cycle of disease through prevention, the country exemplifies a public health model centered on equity, protecting the most vulnerable and ensuring a safer future for Malian women.